Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
58
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Engagement with the Departments of Health and Enterprise regarding the national life science strategy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Meeting to discuss health products reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Senator Teresa Costello (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Department of Health (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meetings with Government Ministers, parliamentarians, and officials with the US Chamber of Commerce delegation in February 2026 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Health | Engagement with the Department of Health on the Life Sciences Strategy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on patient access to new medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Tánaiste Simon Harris (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with HSE on IPHA Agreement and patient access to new medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Albert Nolan TD on biopharma policy priorities (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Industry meeting with Tánaiste on biopharmaceutical policy priorities (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members re new development funding for medicines due for reimbursement in 2025. (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Communication with Robert Watt re reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Briefing for Opposition spokesperson on life sciences industry priorities. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Engagement with John Lahart TD on the Mazars process to reform the reimbursement system (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Conversation with Darren O'Rourke TD (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with Duncan Smith TD on medicines access for Irish patients (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with Sinn Féin at external events (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Conversation with John Lahart TD (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Informal meeting with Pádraig O'Sullivan TD (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with the Taoiseach on medicines access for patients in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with Colm Burke TD on pharmaceutical sector and patient access priorities. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Welcome letters to new Taoiseach and Minister for Enterprise, Trade & Employment (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on reform of the reimbursement process for newly approved medicines (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing information on EU Commission proposal on the revision of pharmaceutical legislation (Legislation) | 4 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Engagement with MEP Kelleher at IIEA policy event on European Health Union and rare disease policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing Information and Views on medicines reimbursement reform and IPHA campaign (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing Information and views on medicines reimbursement reform and patient access (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Meeting with Minister to share views on new EU Pharmaceutical package (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at IPHA Conference on Life Sciences Policy for Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at Health Summit on proposed reforms to medicines reimbursement (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at Health Summit on proposed reforms to medicines reimbursement (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing information on life sciences sector in Ireland & on EU pharmaceutical package (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at IPHA Conference on Proposed Reforms to Medicines Reimbursement (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
| May–Aug 2022 | Janssen Sciences Ireland UC | Health | J&J hosted an exhibit at the ALDE Congress in Dublin, which showcased health and life sciences innovation from across Europe, including cutting edge treatments for cancer, robotic surgery and 3D printing,… (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Invite to webinar series on the 'Future of Value Based Healthcare in Ireland', RCSI Dublin (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Sharing information on challenges in medicines reimbursement process in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Discussion on National Development Plan priorities, energy and environmental policy (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Event at the DePuy Synthes site in Co. Cork to mark the formal launch of Johnson & Johnson entering into an eight-year corporate power purchase agreement in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information of patient research on clinical depression (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) | 10 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Invitation to Discuss Patient Research on Mental Illness (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Health | Sharing progress and information on Janssen COVID19 Vaccine clinical development, supply updates and public communication (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2020 | Janssen Sciences Ireland UC | Health | Sharing information on access to new medicines for Irish patients and COVID-19 vaccine update (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2020 | Janssen Sciences Ireland UC | Health | Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Health | Sharing update on the timeline for the development of JnJ vaccine for COVID-19 and about some of JnJ’s local efforts to assist the health service during pandemic (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Health | Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) | 9 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 58 | 100.0% |